Nikolaj Sorensen

Nikolaj Sorensen is an accomplished executive with extensive experience in the pharmaceutical industry and board governance. Currently serving as a Member of the Board of Directors at Miiskin and a Board Member at Moberg Pharma AB, Nikolaj has held the position of CEO and President at Orexo AB publ since October 2011, where responsibilities encompass global commercial operations, business development, and alliance management. Additional board roles include memberships at Gesynta Pharma AB, Bioservo Technologies, and The Swedish Association of the Pharmaceutical Industry (LIF). Prior marketing leadership at Pfizer Inc involved managing the European marketing team for the Lyrica brand. Educational credentials include M.Sc. degrees in Economics and International Business from Stockholm School of Economics and Copenhagen Business School, as well as a B.Sc. in Economics and Law from Copenhagen Business School.